Skip to main content
. 2019 Apr 1;5(4):312–316. doi: 10.1016/j.jdcr.2019.02.002

Fig 3.

Fig 3

The trends in hemoglobin (A), platelets (B), ESR (C), and CRP (D) are shown before and after treatment with 100-mg daily subcutaneous anakinra. The dark black lines represent the start date of anakinra.